Third-quarter results for Medtronic (NYSE:MDT) included a timeline for a planned label expansion for its automated insulin ...
Despite maintaining its full-year outlook, Medtronic slips in pre-market trading following a revenue miss in its Q3 report.
Medtronic on Tuesday missed Wall Street estimates for third-quarter revenue due to lower purchases of its surgical devices by ...
Medtronic (MDT) stock slips as the company reaffirms full-year outlook after delivering mixed financial for Q3 fiscal 2025.
Medtronic has issued an “Urgent Medical Device Correction” about the accuracy of insulin pump delivery during changes in air pressure, such as airplane takeoffs and landings. “We request you ...
Medtronic PLC’s stock fell 7.3% as the worst performer in the S&P 500 on Tuesday after the medical-products company’s ...
Medtronic stock was down stock was down today after its third-quarter revenue slightly missed the Wall Street analyst consensus.
Medtronic Plc (NYSE:MDT) reported third-quarter 2025 sales of $8.29 billion, missing the consensus of $8.32 billion. The ...
Investor's Business Daily on MSN4d
Why Medtronic Just Undercut Its Buy Zone With A 5% DropMedtronic stock skidded Tuesday after the medtech giant missed sales expectations, though profit came in well ahead of forecasts.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback